Le placebo consiste en une perfusion de NaCl à 0.9% (500mL). clinical trials

Evaluation of Glucocorticoids plus Rituximab Compared to Glucocorticoids Plus Placebo for the Treatment of Patients With Newly-Diagnosed or Relapsing IgA vasculitis: A Prospective, randomized, controlled, double-blind study

This study looks at new treatments for IgA vasculitis (IgAV), focusing on using specific medications (Rituximab or Rixathon) with standard steroid treatment. The aim is to see if these combinations can help patients get into remission and stay there, reducing the need for steroids.